Report overview
If you have latent tuberculosis, you may need to take only one or two types of TB drug. Active tuberculosis, particularly if it's a drug-resistant strain, will require several drugs at once. The most common medications used to treat tuberculosis include:
Isoniazid
Rifampin (Rifadin, Rimactane)
Ethambutol (Myambutol)
Pyrazinamide
This report aims to provide a comprehensive presentation of the global market for Tuberculosis (TB) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis (TB) Treatment. This report contains market size and forecasts of Tuberculosis (TB) Treatment in global, including the following market information:
Global Tuberculosis (TB) Treatment Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Tuberculosis (TB) Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Isoniazid Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Tuberculosis (TB) Treatment include Johnson & Johnson, Otsuka Pharmaceutical Co., Ltd, Macleods Pharmaceutical Ltd, Dong-A ST Co., Ltd, Lupin Ltd, Janssen Products, LP, Mylan and Sanofi, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Tuberculosis (TB) Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tuberculosis (TB) Treatment Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Tuberculosis (TB) Treatment Market Segment Percentages, by Type, 2022 (%)
Isoniazid
Rifampin (Rifadin, Rimactane)
Ethambutol (Myambutol)
Pyrazinamide
Global Tuberculosis (TB) Treatment Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Tuberculosis (TB) Treatment Market Segment Percentages, by Application, 2022 (%)
Active TB
Latent TB
Global Tuberculosis (TB) Treatment Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Tuberculosis (TB) Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tuberculosis (TB) Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Tuberculosis (TB) Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
Otsuka Pharmaceutical Co., Ltd
Macleods Pharmaceutical Ltd
Dong-A ST Co., Ltd
Lupin Ltd
Janssen Products, LP
Mylan
Sanofi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Tuberculosis (TB) Treatment, market overview.
Chapter 2: Global Tuberculosis (TB) Treatment market size in revenue.
Chapter 3: Detailed analysis of Tuberculosis (TB) Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Tuberculosis (TB) Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
